Abstract
Introduction
The impact of IL-12 on decreasing the cytotoxic efficacy of imatinib was inferred from 165 the data using a mathematical model: posterior distribution in parameter α was used to infer whether the effect was greater than 174 zero and significant. A p-value (P (α < 0|M odel, data)) of less 0.05 was considered as 175 significant, that is the data support that IL-12 provides a rescue effect to imatinib. The 176 significance associated with differences in STAT4 and Akt phosphorylation was assessed 177 using a two-tailed homoscedastic t-Test, where a difference with a p-value less than 0.05 was 178 considered significant. 
with the forward and reverse rate constants k f 1 and k r1 , respectively. Assuming that the total 188 number of receptor complexes (T OT RC) are conserved, the amount of activated receptor in 189 equilibrium with the ligand concentration is given by:
where K C is equal to k r1 /k f 1 . Similarly, a non-canonical receptor-dependent mechanism
191
represents the spontaneous change in activity of a receptor complex:
At equilibrium, the amount of activated receptor is given by:
where K N is equal to k r2 /k f 2 . The hybrid model combines both mechanisms:
194
IL12 + RC
with the equilibrium relationships:
Based on the relative abundance of IL-12 receptor proteins, we assumed that the total 
which is catalyzed by a generic phosphatase (P ASE) with a rate constant of k D and captures a given abundance of activated receptor complex (ARC) at steady state is:
where K D is equal to k D ·P ASE/k A . T OT S and K D were free parameters used in calibrating
210
the mathematical models to the data. The three competing models are expressed as:
Non-canonical: conditions. The ligand binding constant, K C , was determined for each cell line, as extracel-215 lular binding affinity should not influence the specificity of intracellular signal transduction.
216
As the number of experimental observations (N obs ≥ 69) exceeded the number of free param-217 eters (N parameters ≤ 4), the model parameters were theoretically identifiable from the data.
218
A summed squares of the error (SSE) metric was used as a goodness-of-fit for model i: 
where 
where N obs is the number of observations of the experimental variable. To interpret the 
229

Results
230
To investigate whether IL12RB2 provides an intrinsic advantage to the B16F0 cell line, we 
329
Pre-conditioning cells in the absence of serum was critical to observe differences in Akt 330 phosphorylation.
331
To determine whether Akt activation in the B16 melanoma line was specific, we repeated Conventionally, signal transduction within the IL-12 pathway is comprised of three steps.
345
The first step involves a change in conformation of the multi-protein receptor complex upon 346 ligand binding that promotes receptor kinase activity. Upon gaining kinase activity, the 347 receptor complex phosphorylates signaling intermediates, like STAT4. In the third step, used to compare how well each competing mechanism captured the data.
362
In regressing the mathematical models to the data, the ligand binding constant, favored over STAT4, which is the canonical signal transducer in the IL-12 pathway.
418
To extend our focus beyond mouse cell models, we also wondered whether similar patterns 419 of gene expression are observed in human melanoma based on single cell RNA-seq analysis.
420
In a study of 31 human melanoma tumors (Figure 7) to promote survival in response to cytokines within the tumor environment.
451
In Figure 8 , we propose a mechanism by which rewiring of the canonical IL-12 pathway was assessed using a two-tailed homoscedastic t-Test, where ** indicates a p-value < 0.005 699 and * indicates a p-value < 0.05. No IL-12 7 ng/ml 100 ng/ml 300 ng/ml 
